Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 30, 2011
February 1, 2021
bffc25a1-1a64-42bf-9751-1502844fa83e
Related Documents
Internet/Social Media Platforms with Character Space Limitations— Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices
Guidance DocumentJune 18, 2014Center for Drug Evaluation and Research
Drug Interaction Information in Human Prescription Drug and Biological Product Labeling
Guidance DocumentOctober 21, 2024Center for Drug Evaluation and Research
Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics
Guidance DocumentJanuary 14, 2014Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox